Lung cancer immunotherapy: Programmatic development, progress, and perspectives

Edward A. Hirschowitz; Terry H. Foody; John R. Yannelli

doi:10.1007/978-3-7091-1419-3_23

Lung cancer immunotherapy: Programmatic development, progress, and perspectives

Edward A. Hirschowitz, Terry H. Foody, John R. Yannelli

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

This chapter describes a decade of experience with lung cancer vaccine development at a single institution. Elements of review include rationale, developmental strategy, scientific approach relative to historical perspective, and clinical circumstance.

Original language	English
Title of host publication	From Prophylaxis to Therapy
Pages	385-396
Number of pages	12
Volume	1
ISBN (Electronic)	9783709114193
DOIs	https://doi.org/10.1007/978-3-7091-1419-3_23
State	Published - Oct 1 2013

Bibliographical note

Publisher Copyright:
© 2013 Springer-Verlag Wien. All rights reserved.

ASJC Scopus subject areas

General Medicine
General Immunology and Microbiology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-3-7091-1419-3_23

Cite this

@inbook{7f5ca999145f44119b7c265167cb7f73,

title = "Lung cancer immunotherapy: Programmatic development, progress, and perspectives",

abstract = "This chapter describes a decade of experience with lung cancer vaccine development at a single institution. Elements of review include rationale, developmental strategy, scientific approach relative to historical perspective, and clinical circumstance.",

author = "Hirschowitz, {Edward A.} and Foody, {Terry H.} and Yannelli, {John R.}",

year = "2013",

month = oct,

day = "1",

doi = "10.1007/978-3-7091-1419-3_23",

language = "English",

isbn = "3709114187",

volume = "1",

pages = "385--396",

booktitle = "From Prophylaxis to Therapy",

}

TY - CHAP

T1 - Lung cancer immunotherapy

T2 - Programmatic development, progress, and perspectives

AU - Hirschowitz, Edward A.

AU - Foody, Terry H.

AU - Yannelli, John R.

PY - 2013/10/1

Y1 - 2013/10/1

N2 - This chapter describes a decade of experience with lung cancer vaccine development at a single institution. Elements of review include rationale, developmental strategy, scientific approach relative to historical perspective, and clinical circumstance.

AB - This chapter describes a decade of experience with lung cancer vaccine development at a single institution. Elements of review include rationale, developmental strategy, scientific approach relative to historical perspective, and clinical circumstance.

UR - http://www.scopus.com/inward/record.url?scp=84930738000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930738000&partnerID=8YFLogxK

U2 - 10.1007/978-3-7091-1419-3_23

DO - 10.1007/978-3-7091-1419-3_23

M3 - Chapter

AN - SCOPUS:84948175609

SN - 3709114187

SN - 9783709114186

VL - 1

SP - 385

EP - 396

BT - From Prophylaxis to Therapy

ER -

Lung cancer immunotherapy: Programmatic development, progress, and perspectives

Abstract

Bibliographical note

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this